Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734536 · ClinicalTrials.gov registry record · NA
Treatment of Partial-Thickness Rotator Cuff Tears
A NA study, sponsored by Smith & Nephew.
- Terminated
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT03734536: Clinical Trial NA study, sponsored by Smith & Nephew.
NCT03734536 is a NA study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03734536, a NA study, was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (\>50%) partial-thickness tears.
Primary Outcome
American Shoulder and Elbow Surgeons (ASES) score at baseline and 3 months following index surgery. ASES is composed of 2 sections containing participant self-reported and clinician assessments. The ASES score is a 0 to 100-point rating based solely on participant responses and is a combination of the participant's shoulder pain rating (VAS Pain) and self-reported ability to perform 10 different activities of daily living (ADLs). A higher score is a better outcome.
Interventions
- DEVICE REGENETEN™ Bioinductive Implant
- DEVICE Arthroscopic repair of the high-grade (>50%) partial-thickness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2023-09-11 |
| Phase | NA |
Why NCT03734536 stopped before completion
NCT03734536 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which REGENETEN™ Bioinductive Implant is the first listed.
NCT03734536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03734536 about?
NCT03734536 is a clinical study titled "Treatment of Partial-Thickness Rotator Cuff Tears". The goal of this clinical trial is to demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (\>50%) partial-thickness tears.
What is the current status of trial NCT03734536?
This trial is currently terminated. It is a NA study. The enrollment target is 168 participants. The study started on 2018-12-05. Estimated completion is 2023-09-11.
What interventions are being tested in trial NCT03734536?
The interventions under investigation include: REGENETEN™ Bioinductive Implant (DEVICE), Arthroscopic repair of the high-grade (>50%) partial-thickness (DEVICE).
Who is sponsoring clinical trial NCT03734536?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03734536's enrollment target sits among peer trials
168 619th of 2000 higher than 1,379 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI